This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Transitory endocrine and metabolic disorders specific to fetus and newborn
P16_TRANSITO_ENDOCR_METABOLIC_DISORD_SPECIFIC_FETUS_NEWBO
No definition available.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
321
Check minimum number of events None
321
Include endpoints
321
Remove individuals based on genotype QC
305
P16_TRANSITO_ENDOCR_METABOLIC_DISORD_SPECIFIC_FETUS_NEWBO
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P
Name in latin
Morbositates transitoriae endocrinae et metabolicae fetus et neonati specificae
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Transitory endocrine and metabolic disorders specific to fetus and newborn
based on the number of shared cases.
Broader endpoints:
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 305 | 168 | 137 |
| Unadjusted prevalence (%) | 0.08 | 0.08 | 0.08 |
| Mean age at first event (years) | 0.40 | 0.72 | 0.00 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: P16_TRANSITO_ENDOCR_METABOLIC_DISORD_SPECIFIC_FETUS_NEWBO – Transitory endocrine and metabolic disorders specific to fetus and newborn
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Transitory endocrine and metabolic disorders specific to fetus and newborn
↥Endpoint not on priority list, no data to show.